This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bullous Diseases  • Pemphigus  • Immunologic Disorders  • Alert me on articles by topic

Autoimmune Induction in Antibody-Mediated Blistering Skin Diseases

Arch Dermatol. 2000;136:663-664.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

WITHIN THE last 10 years, an immunologic phenomenon termed epitope spreading has been increasingly recognized as an important pathogenic mechanism responsible for the initiation and/or progression of autoimmune diseases.^1-2 Epitope spreading could be defined as a specific autoreactive lymphocyte (T- or B-cell) response to endogenous epitopes, which are distinct from and non–cross-reactive with the disease-inducing epitopes, on the (same or different) proteins secondary to the release of such a self-protein during an autoimmune response.^2-3 Similarly, a specific primary autoreactive lymphocyte response to endogenous epitopes can arise from an inflammatory injury that releases the involved epitopes.^2-3 In other words, an autoimmune or inflammatory disease process can cause tissue damage such that certain protein tissue components originally hidden from the autoreactive T or B cells become exposed and evoke a secondary or primary autoimmune response, respectively (Figure 1).^2-3

Figure appears in full text version. Model of epitope spreading. The presentation of the primary epitope to the . . . [Full Text of this Article]

RELATED ARTICLE

Lichenoid Dermatitis in Paraneoplastic Pemphigus: A Pathogenic Trigger of Epitope Spreading?
Glen M. Bowen, Neill T. Peters, David P. Fivenson, Lyndon D. Su, Hossein C. Nousari, Grant J. Anhalt, Kevin D. Cooper, and Seth R. Stevens
Arch Dermatol. 2000;136(5):652-656.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Paraneoplastic Pemphigus Associated With Castleman Tumor: A Commonly Reported Subtype of Paraneoplastic Pemphigus in China
Wang et al.
Arch Dermatol 2005;141:1285-1293.
ABSTRACT | FULL TEXT  

Antibody Titers to Desmogleins 1 and 3 in a Patient With Paraneoplastic Pemphigus Associated With Follicular Dendritic Cell Sarcoma
Seishima et al.
Arch Dermatol 2004;140:1500-1503.
ABSTRACT | FULL TEXT  

Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?
Burt et al.
Blood 2002;99:768-784.
ABSTRACT | FULL TEXT  

Classification, Clinical Manifestations, and Immunopathological Mechanisms of the Epithelial Variant of Paraneoplastic Autoimmune Multiorgan Syndrome: A Reappraisal of Paraneoplastic Pemphigus
Nguyen et al.
Arch Dermatol 2001;137:193-206.
ABSTRACT | FULL TEXT